1. Home
  2. GTHX
  3. GTHX News

Latest G1 Therapeutics Inc. (GTHX) News on May 29, 2024

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)

GlobeNewswire

17 hours ago

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)

Thomson Reuters StreetEvents

a month ago

Q1 2024 G1 Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

3 months ago

Q4 2023 G1 Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

7 months ago

Q3 2023 Kaltura Inc Earnings Call

Share on Social Networks: